ライフサイエンスコーパス: fundus autofluorescence

1 s photography, spectral-domain OCT [SD-OCT], fundus autofluorescence).

2 ral-domain optical coherence tomography, and fundus autofluorescence.

3 ation plots), SD-OCT, and sometimes mfERG or fundus autofluorescence.

4 ger wavelengths, a characteristic typical of fundus autofluorescence.

5 n retinal diseases characterized by aberrant fundus autofluorescence.

6 e was measurable by HPLC and by quantitative fundus autofluorescence.

7 iography, indocyanine green angiography, and fundus autofluorescence.

8 ion of retinal pigment epithelium atrophy on fundus autofluorescence.

9 nsistent results for GA growth compared with fundus autofluorescence.

10 fundus photography, spectral-domain OCT, and fundus autofluorescence.

11 t, visibility on funduscopy, ultrasound, and fundus autofluorescence.

12 g the growth of atrophic lesions measured by fundus autofluorescence.

13 cidence of atrophic lesions as determined by fundus autofluorescence.

14 diameter of a paracentral ring of increased fundus autofluorescence.

15 ristic imaging on fluorescein angiography or fundus autofluorescence; (3) absent to mild anterior cha

16 Fundus autofluorescence abnormalities were seen in 24 ey

17 tively sparing the fovea; (4) characteristic fundus autofluorescence abnormalities; (5) full-field el

18 Fundus autofluorescence (AF) images (55 degrees lens, 48

19 en MIDD and demarcated RPE atrophy on serial fundus autofluorescence (AF) images were included.

20 Fundus autofluorescence (AF) imaging allows non-invasive

21 on assessment, color fundus photography, and fundus autofluorescence (AF) imaging.

22 Measures of retinal structure and fundus autofluorescence (AF) were correlated with visual

23 visual acuity (BCVA), widefield angiography, fundus autofluorescence (AF), and wnt signaling pathway

24 surements using two techniques (2-wavelength fundus autofluorescence [AF] and heterochromatic flicker

25 main optical coherence tomography (OCT), and fundus autofluorescence analysis were performed in patie

26 imaging including color fundus photography, fundus autofluorescence and cross sectional and en-face

27 Fundus autofluorescence and electrophysiological testing

28 Longitudinal fundus autofluorescence and infrared reflectance images

29 and optical coherence tomography (along with fundus autofluorescence and multifocal electroretinograp

30 ence tomography features and staging system, fundus autofluorescence and near-infrared reflectance fe

31 ata, signs and symptoms, visual acuity (VA), fundus autofluorescence and OCT findings, ERG phenotype,

32 of clinical notes, retinal imaging including fundus autofluorescence and OCT, electroretinography (ER

33 Fundus autofluorescence and optical coherence tomography

34 Newer imaging modalities such as fundus autofluorescence and spectral domain optical cohe

35 lor fundus photography, automated perimetry, fundus autofluorescence and spectral domain optical cohe

36 derwent best-corrected visual acuity (BCVA), fundus autofluorescence and spectral domain-optical cohe

37 Blue fundus autofluorescence and spectral-domain OCT were obt

38 e evaluated the multimodal imaging including fundus autofluorescence and spectral-domain optical cohe

39 onal and morphologic examinations, including fundus autofluorescence and spectral-domain optical cohe

40 Fundus autofluorescence and spectral-domain optical cohe

41 trophy was delineated on the basis of serial fundus-autofluorescence and infrared-reflectance images.

42 ed the foveal attenuation normally seen with fundus autofluorescence, and a concentric macular rings

43 infrared reflectance, hypoautofluorescent on fundus autofluorescence, and as subretinal deposits on s

44 ptic nerve head (ONH), infrared reflectance, fundus autofluorescence, and color fundus photographs (C

45 with biomicroscopy, OCT and OCT angiography, fundus autofluorescence, and fluorescein and indocyanine

46 rimetry, optical coherence tomography (OCT), fundus autofluorescence, and fundus photography.

47 color photography, fluorescein angiography, fundus autofluorescence, and high-resolution optical coh

48 ncluding optical coherence tomography (OCT), fundus autofluorescence, and indocyanine green and fluor

49 ndus photography or MultiColor imaging, OCT, fundus autofluorescence, and OCT angiography were includ

50 color photography, fluorescein angiography, fundus autofluorescence, and optical coherence tomograph

51 Fluorescein angiography, fundus autofluorescence, and optical coherence tomograph

52 l field, and full-field electroretinography, fundus autofluorescence, and optical coherence tomograph

53 Color fundus photographs, fundus autofluorescence, and spectral-domain OCT were ob

54 ear interval with near-infrared reflectance, fundus autofluorescence, and spectral-domain OCT.

55 uded change from baseline in microperimetry, fundus autofluorescence, and spectral-domain optical coh

56 nd clinical information, fundus photographs, fundus autofluorescence, and spectral-domain-OCT (SD-OCT

57 CFP and fundus autofluorescence are key imaging modalities for t

58 ering) could produce a cross-shaped increase fundus autofluorescence artifact on subsequent imaging.

59 ral color fundus and optic disc photography, fundus autofluorescence, automated perimetry, and optica

60 n area of increased autofluorescence on blue fundus autofluorescence (B-FAF).

61 coherence tomography (FD-OCT) and blue-light fundus autofluorescence (bAF).

62 ence (GAF; Clarus, Carl Zeiss Meditec), blue fundus autofluorescence (BAF; Spectralis, Heidelberg Eng

63 hy (OCT), fluorescein angiography (FA), blue fundus autofluorescence (BFAF), en face OCT, and OCT ang

64 visual acuity with ETDRS charts, blue-light fundus autofluorescence, (BL-FAF), near-infrared fundus

65 Fundus autofluorescence correlated with structural alter

66 o short-wavelength light resulted in reduced fundus autofluorescence, decreased HPLC-quantified A2E,

67 Fundus autofluorescence demonstrated interposed, reduced

68 Fundus autofluorescence demonstrated mild hyperautofluor

69 Fundus autofluorescence disclosed hypoautofluorescence (

70 Fundus autofluorescence (FAF) and color fundus (CF) phot

71 he enlargement of the atrophic lesions using fundus autofluorescence (FAF) and color fundus photograp

72 coherence tomography (OCT), OCT-Angiography, fundus autofluorescence (FAF) and fluorescein-angiograph

73 almoscopy, and fundus photography, including fundus autofluorescence (FAF) and near-infrared reflecta

74 of at least 4 years and had undergone annual fundus autofluorescence (FAF) and OCT imaging using Heid

75 basis of full-field electroretinogram (ERG) Fundus autofluorescence (FAF) and spectral domain-optica

76 Blue-light fundus autofluorescence (FAF) and spectral-domain OCT (S

77 e of change in GA over 12 months measured by fundus autofluorescence (FAF) at 3 timepoints: baseline,

78 Monthly BCVA and fundus autofluorescence (FAF) at baseline and every 6 mo

79 jective corroboration for visual fields, and fundus autofluorescence (FAF) can show damage topographi

80 Fundus autofluorescence (FAF) decays were detected in sh

81 ion algorithm and correlated with SD OCT and fundus autofluorescence (FAF) findings.

82 Eyes were evaluated on fundus autofluorescence (FAF) for GA.

83 Fundus autofluorescence (FAF) illustrated speckled hyper

84 Fundus autofluorescence (FAF) images from a subset of AR

85 multaneous fundus photographs and SD OCT and fundus autofluorescence (FAF) images of eyes affected wi

86 The 200 degrees pseudocolor and fundus autofluorescence (FAF) images were captured on th

87 3 weeks and after 6 weeks, respectively, and fundus autofluorescence (FAF) images were obtained to vi

88 acula volume scans centered at the fovea and fundus autofluorescence (FAF) images were obtained.

89 Fundus autofluorescence (FAF) imaging and optical cohere

90 Fundus autofluorescence (FAF) imaging is crucial to the

91 tinal detachment with gradable postoperative fundus autofluorescence (FAF) imaging were included in t

92 s photography, optical coherence tomography, fundus autofluorescence (FAF) imaging, and audiologic an

93 l-domain optical coherence tomography (OCT), fundus autofluorescence (FAF) imaging, full-field electr

94 Electrophysiological assessment, fundus autofluorescence (FAF) imaging, fundus fluorescei

95 l-domain optical coherence tomography (OCT), fundus autofluorescence (FAF) imaging, Humphrey visual f

96 trawidefield (UWF) color fundus photography, fundus autofluorescence (FAF) imaging, OCT, and electror

97 s photography, fluorescein angiography (FA), fundus autofluorescence (FAF) imaging, optical coherence

98 us photography, near-infrared (NIR) imaging, fundus autofluorescence (FAF) imaging, spectral domain o

99 logic examination, color fundus photography, fundus autofluorescence (FAF) imaging, spectral-domain (

100 In all probands, fundus autofluorescence (FAF) imaging, spectral-domain o

101 thalmologic examination, fundus photography, fundus autofluorescence (FAF) imaging, spectral-domain o

102 n enlargement from baseline as assessed with fundus autofluorescence (FAF) imaging.

103 Characteristics of GA were examined using fundus autofluorescence (FAF) imaging.

104 n optical coherence tomography (SD-OCT), and fundus autofluorescence (FAF) imaging.

105 n optical coherence tomography (SD-OCT), and fundus autofluorescence (FAF) imaging.

106 ain optical coherence tomography (SDOCT) and fundus autofluorescence (FAF) imaging.

107 in optical coherence tomography (SD OCT) and fundus autofluorescence (FAF) imaging.

108 sed primarily by color fundus photography or fundus autofluorescence (FAF) imaging.

109 Most studies of fundus autofluorescence (FAF) in geographic atrophy (GA)

110 ots corresponding to focal dots of decreased fundus autofluorescence (FAF) surrounded by increased FA

111 main optical coherence tomography (OCT), and fundus autofluorescence (FAF) to confirm a diagnosis.

112 contribution of retro-mode imaging (RMI) and fundus autofluorescence (FAF) to the characterization of

113 in optical coherence tomography (SD-OCT) and fundus autofluorescence (FAF) underwent testing for best

114 omain optical coherence tomography (SD OCT), fundus autofluorescence (FAF), and fluorescein angiograp

115 rimetry, optical coherence tomography (OCT), fundus autofluorescence (FAF), and fundus photography.

116 omain optical coherence tomography (SD-OCT), fundus autofluorescence (FAF), and infrared reflectance

117 with conventional multimodal imaging (color, fundus autofluorescence (FAF), and infrared reflectance

118 omain optical-coherence-tomography (SD-OCT), fundus autofluorescence (FAF), and near-infrared-reflect

119 ear-infrared (NIR) and short-wavelength (SW) fundus autofluorescence (FAF), and NIR reflectance (REF)

120 (ICGA), optical coherence tomography (OCT), fundus autofluorescence (FAF), and OCT angiography (OCTA

121 s of TARP on widefield fundus color imaging, fundus autofluorescence (FAF), and OCT were described.

122 ompared with automated visual fields (AVFs), fundus autofluorescence (FAF), and optical coherence tom

123 Near-infrared reflectance (NIR), fundus autofluorescence (FAF), and optical coherence tom

124 ded 35 degrees fundus photography, infrared, fundus autofluorescence (FAF), and SD-OCT.

125 g including near-infrared reflectance (NIR), fundus autofluorescence (FAF), and spectral domain optic

126 rom near-infrared reflectance (NIR) imaging, fundus autofluorescence (FAF), and spectral domain-optic

127 Color fundus photography, fundus autofluorescence (FAF), and spectral-domain OCT (

128 tion together with color fundus photography, fundus autofluorescence (FAF), and spectral-domain optic

129 ude color fundus photography (CFP), confocal fundus autofluorescence (FAF), confocal near-infrared re

130 plete ophthalmological examination including fundus autofluorescence (FAF), dynamic simultaneous fluo

131 (BCVA), ophthalmoscopy, fundus photography, fundus autofluorescence (FAF), fluorescein angiography (

132 undus examination, color fundus photographs, fundus autofluorescence (FAF), fluorescein angiography (

133 y (PAM), optical coherence tomography (OCT), fundus autofluorescence (FAF), fluorescein angiography (

134 and recurrent CSCR were reviewed, including fundus autofluorescence (FAF), fluorescein angiography (

135 static perimetry, fundus color photography, fundus autofluorescence (FAF), fundus fluorescein angiog

136 ct ophthalmoscopy, color fundus photography, fundus autofluorescence (FAF), high-resolution optical c

137 thalmologic examination, fundus photography, fundus autofluorescence (FAF), infrared imaging, and spe

138 chart, fundus photography, ultrasonography, fundus autofluorescence (FAF), infrared reflectance (IR)

139 ng best-corrected visual acuity (BCVA), blue fundus autofluorescence (FAF), near-infrared autofluores

140 uding color and red-free fundus photography, fundus autofluorescence (FAF), near-infrared reflectance

141 fundus photography, fluorescein angiography, fundus autofluorescence (FAF), near-infrared reflectance

142 faster-growing lesions from 2 eyes based on fundus autofluorescence (FAF), near-infrared reflectance

143 s who underwent serial ultrawide-field (UWF) fundus autofluorescence (FAF), OCT, and Macular Integrit

144 visual acuity of 20/25 or better and normal fundus autofluorescence (FAF), OCT, multicolor, near-inf

145 to assess the correlations between standard fundus autofluorescence (FAF), optical coherence tomogra

146 sual acuity (BCVA), color fundus photograph, fundus autofluorescence (FAF), optical coherence tomogra

147 omain optical coherence tomography (SD OCT), fundus autofluorescence (FAF), or multifocal electroreti

148 uscin accumulation, as measured by increased fundus autofluorescence (FAF), precedes progression or d

149 visits for at least 1 examination modality: fundus autofluorescence (FAF), spectral-domain (SD) opti

150 ng was completed for each patient; including fundus autofluorescence (FAF), spectral-domain optical c

151 gment epithelium (RPE) is the main source of fundus autofluorescence (FAF), the target of an imaging

152 ected visual acuity (BCVA) determination and fundus autofluorescence (FAF).

153 y (FP), OCT, fluorescein angiogram (FA), and fundus autofluorescence (FAF).

154 rimetry, full-field electroretinography, and fundus autofluorescence (FAF).

155 omain ocular coherence tomography (OCT), and fundus autofluorescence (FAF).

156 in all 7 patients, corresponding to abnormal fundus autofluorescence (FAF).

157 in optical coherence tomography (SD OCT) and fundus autofluorescence (FAF).

158 ellipsoid zone (EZ) area, and total area of fundus autofluorescence (FAF).

159 eutic effects in GA compared to conventional fundus autofluorescence (FAF).

160 ment epithelium (RPE) is the major source of fundus autofluorescence (FAF).

161 al RPE area in untreated eyes with CHM using fundus autofluorescence (FAF).

162 Eyes were examined longitudinally with fundus autofluorescence (FAF; excitation wavelength, 488

163 [SD] optical coherence tomography [OCT], and fundus autofluorescence [FAF]) then were reviewed.

164 growth rates per disease, imaging modality (fundus autofluorescence [FAF], optical coherence tomogra

165 Optical coherence tomography and fundus autofluorescence findings suggest that group V ph

166 ng system of SC lesions based on SS-OCTA and fundus autofluorescence findings.

167 fundus imaging, including color photographs, fundus autofluorescence, fluorescein angiography, and in

168 ld imaging included pseudocolor photography, fundus autofluorescence, fluorescein angiography, and in

169 r detachments based on clinical examination, fundus autofluorescence, fluorescein angiography, and op

170 ubmaculopathy based on clinical examination, fundus autofluorescence, fluorescein angiography, and sp

171 ation, fundus photography, infrared imaging, fundus autofluorescence, fluorescein angiography, and sp

172 Fundus photography, fundus autofluorescence, fluorescein angiography, indocy

173 Fundus autofluorescence, fluorescein angiography, optica

174 Fundus autofluorescence (fundus AF) changes were monitor

175 Fundus autofluorescence, fundus color photography, and s

176 erence tomography (angiography) (SD-OCT(A)), fundus autofluorescence, fundus photography, infrared im

177 uding near-infrared reflectance (NIR), green fundus autofluorescence (G-FAF), confocal pseudocolor, a

178 (Spectralis, Heidelberg Engineering), green fundus autofluorescence (GAF; Clarus, Carl Zeiss Meditec

179 The fundus autofluorescence generally represents the status

180 reen angiography, near-infrared reflectance, fundus autofluorescence, high-resolution OCT, and ultraw

181 Presence of RPD was from grading of fundus autofluorescence images (AREDS2) and deep learnin

182 nt epithelium (RPE) atrophy was performed on fundus autofluorescence images and OCT scans.

183 east 1 eye at the most recent visit, and (2) fundus autofluorescence images for at least 2 visits wit

184 Fundus autofluorescence images obtained from patient vis

185 Fundus autofluorescence images of 30 degrees and 55 degr

186 Fundus autofluorescence images of eyes with GA were obta

187 A series of 3 fundus autofluorescence images using 3 different acquisi

188 ain optical coherence tomography (SDOCT) and fundus autofluorescence images were acquired every 6 mon

189 OCT and fundus autofluorescence images were analyzed to identify

190 Fundus autofluorescence images were not available.

191 rophic regions detected on serial registered fundus autofluorescence images were semiautomatically de

192 these patients, 215 had at least 2 gradable fundus autofluorescence images with atrophic lesion(s) p

193 aluated, including color fundus photographs, fundus autofluorescence images, and spectral-domain OCT

194 tofluorescent AZOOR line in short-wavelength fundus autofluorescence images, delineating the peripapi

195 papillary sparing is a consistent feature on fundus autofluorescence images, whereas the same region

196 ripapillary sparing as consistent feature on fundus autofluorescence images.

197 fundus examination, Goldmann visual fields, fundus autofluorescence imaging (FAF), optical coherence

198 hanges visible upon clinical examination and fundus autofluorescence imaging (occult retinopathy).

199 Fundus autofluorescence imaging and optical coherence to

200 responded to hyperautofluorescent lesions on fundus autofluorescence imaging and subretinal hyperrefl

201 Fundus autofluorescence imaging can reveal the extent of

202 a normal retinal appearance, although their fundus autofluorescence imaging demonstrated foci of inc

203 optical coherence tomography and to describe fundus autofluorescence imaging in this condition.

204 Fundus autofluorescence imaging is abnormal in children

205 ity, fundus-tracked microperimetry, OCT, and fundus autofluorescence imaging performed.

206 The electrophysiological and fundus autofluorescence imaging presented here should fa

207 Fundus autofluorescence imaging remained normal.

208 Quantitative fundus autofluorescence imaging revealed characteristic

209 Fundus autofluorescence imaging showed a parafoveal annu

210 elength reduced-illuminance and conventional fundus autofluorescence imaging showed good concordance

211 l patients underwent spectral-domain OCT and fundus autofluorescence imaging using the Spectralis HRA

212 Fundus autofluorescence imaging was not used.

213 In selected cases, fundus autofluorescence imaging was performed.

214 Fundus autofluorescence imaging was used to evaluate GA

215 l coherence tomography (OCT), and blue light fundus autofluorescence imaging were performed for all p

216 graphy (CFP), near-infrared reflectance, and fundus autofluorescence imaging were performed in all pa

217 uorescein and indocyanine green angiography, fundus autofluorescence imaging, and corresponding eye-t

218 l-domain optical coherence tomography (OCT), fundus autofluorescence imaging, and electroretinogram (

219 eld electroretinography, fundus photography, fundus autofluorescence imaging, and optical coherence t

220 clinically by wide-field color photography, fundus autofluorescence imaging, and spectral-domain opt

221 linical examination, fundus photography, and fundus autofluorescence imaging, and visual function was

222 and detailed retinal imaging was performed: fundus autofluorescence imaging, digital color fundoscop

223 tance, red-free images and blue reflectance, fundus autofluorescence imaging, indocyanine green angio

224 molecular genetic testing, retinal imaging (fundus autofluorescence imaging, optical coherence tomog

225 erations on optical coherence tomography and fundus autofluorescence imaging, retinal function assess

226 fundus examination, wide-field photography, fundus autofluorescence imaging, sedated electroretinogr

227 including fundus photography, infra-red and fundus autofluorescence imaging, spectral-domain optical

228 ectral-domain OCT, color fundus photography, fundus autofluorescence imaging, visual field testing, f

229 ated with marked loss of autofluorescence on fundus autofluorescence imaging.

230 ve on NIR reflectance and hypofluorescent on fundus autofluorescence imaging.

231 ded by a continuous hyperfluorescent ring on fundus autofluorescence imaging.

232 ral-domain optical coherence tomography, and fundus autofluorescence imaging.

233 tral domain optical coherence tomography and fundus autofluorescence imaging.

234 ral-domain optical coherence tomography, and fundus autofluorescence imaging.

235 Area and growth of GA were measured using fundus autofluorescence imaging.

236 T and corresponding hyperautofluorescence on fundus autofluorescence imaging.

237 aser ophthalmoscopy infrared reflectance and fundus autofluorescence imaging.

238 The dots were hyperautofluorescent on fundus autofluorescence imaging.

239 main optical coherence tomography (OCT), and fundus autofluorescence imaging.

240 ents with Stargardt disease as determined by fundus autofluorescence imaging.

241 produced a striking leopard-spot pattern on fundus autofluorescence imaging.

242 ultrawide-field color fundus photography and fundus autofluorescence imaging; and spectral domain-OCT

243 We assessed the utility of quantified fundus autofluorescence in (FAF) the evaluation and foll

244 We assessed the utility of quantification of fundus autofluorescence in the evaluation and follow-up

245 Most importantly, we also observed reduced fundus autofluorescence in the eyes injected with NP and

246 tudies that monitored atrophy progression by fundus autofluorescence in untreated eyes with STGD1 for

247 chart, fundus photography, ultrasonography, fundus autofluorescence, infrared reflectance (IR) imagi

248 he retina included color fundus photography, fundus autofluorescence, intravenous fluorescein angiogr

249 ield and pattern), visual evoked potentials, fundus autofluorescence IRR, and optical coherence tomog

250 Fundus autofluorescence is a helpful, fast, and noninvas

251 Fundus autofluorescence is a noninvasive technique for e

252 Fundus autofluorescence is a valuable imaging tool in th

253 Fundus autofluorescence is the most important tool for a

254 n area was larger than both the ONL-slab and fundus autofluorescence lesion areas.

255 In Stargardt disease with DDAF lesions, fundus autofluorescence may serve as a monitoring tool f

256 etinal fluid on OCT, hypoautofluorescence on fundus autofluorescence, middle to outer retinal hyperva

257 pectral-domain optical coherence tomography, fundus autofluorescence, multifocal electroretinography,

258 Fundus autofluorescence, near-infrared reflectance, and

259 Other methods, including fundus autofluorescence, near-infrared reflectance, and

260 dal retinal imaging, including near-infrared fundus autofluorescence (NIR-AF), blue autofluorescence

261 us autofluorescence, (BL-FAF), near-infrared fundus autofluorescence (NIR-FAF), and RMI.

262 pectralis, Heidelberg Engineering, Germany), fundus autofluorescence, OCT angiography (RTVue XR Avant

263 , retinal imaging (color fundus photography, fundus autofluorescence, OCT), electrophysiologic assess

264 graphy (OCT), en face near-infrared imaging, fundus autofluorescence, optical coherence tomography an

265 ross studies using color fundus photography, fundus autofluorescence, or OCT (P = 0.35-0.99).

266 Interestingly, no changes in macular fundus autofluorescence pattern were evident after optic

267 Quantitative fundus autofluorescence (qAF) and spectral-domain optica

268 110 control subjects underwent quantitative fundus autofluorescence (qAF) imaging using a confocal s

269 articipants were examined using quantitative fundus autofluorescence (qAF) imaging with a modified co

270 SW-AF intensities, measured as quantitative fundus autofluorescence (qAF), indicated chronic impairm

271 length fundus autofluorescence (quantitative fundus autofluorescence [qAF]) and spectral-domain optic

272 ndus lesions by quantifying short-wavelength fundus autofluorescence (quantitative fundus autofluores

273 domain OCT results, OCT angiography results, fundus autofluorescence results, ultra-widefield fluores

274 Fundus autofluorescence showed little or no change excep

275 Fundus autofluorescence showed zonal areas of hypoautofl

276 y evaluations, GA lesion area as measured by fundus autofluorescence, spectral domain optical coheren

277 ite 10-2 visual field pattern density plots, fundus autofluorescence, spectral-density optical cohere

278 acuity, slit-lamp biomicroscopy, fundoscopy, fundus autofluorescence, spectral-domain optical coheren

279 included short-wavelength and near-infrared fundus autofluorescence, spectral-domain optical coheren

280 In short-wavelength fundus autofluorescence (SW-AF) images, speckled hyperau

281 e symmetry that presents on short-wavelength fundus autofluorescence (SW-AF) imaging with hyperautofl

282 tical coherence tomography, short-wavelength fundus autofluorescence (SW-AF), quantitative autofluore

283 nce tomography (SD-OCT) and short wavelength fundus autofluorescence (SW-AF).

284 ctional back-scattering and short-wavelength fundus autofluorescence (SW-FAF) to study disease-relate

285 erized clinically and imaged with short-wave fundus autofluorescence (SW-FAF), spectral-domain optica

286 the hyperautofluorescent ring on short-wave fundus autofluorescence (SW-FAF).

287 In vivo measurement of fundus autofluorescence, the source of which is bisretin

288 idenced by HPLC analysis and quantitation of fundus autofluorescence; this effect is consistent with

289 pth imaging (EDI)-OCT, swept source OCT, and fundus autofluorescence using a fundus camera.

290 aluate the disease extent on ultra-widefield fundus autofluorescence (UWF-FAF) in patients with ABCA4

291 CI, 0.42-0.61 mm2/y), and of total decreased fundus autofluorescence was 0.35 mm2/y (95% CI, 0.28-0.4

292 f patients exhibiting annular RPE lesions on fundus autofluorescence was included for chart review an

293 Repeat fundus autofluorescence was obtained at 12, 24, 36, and

294 Fundus autofluorescence was quantified (qAF) in subjects

295 No significant increases of fundus autofluorescence were detected by SLO imaging of

296 uding optical coherence tomography (OCT) and fundus autofluorescence were evaluated at the baseline a

297 tients, and optical coherence tomography and fundus autofluorescence were performed in 4 patients.

298 Fluorescein angiography and fundus autofluorescence were useful in determining lesio

299 ral OCT, near-infrared reflectance, and blue fundus autofluorescence, were investigated.

300 ncluding near-infrared (NIR) reflectance and fundus autofluorescence with a confocal scanning laser o